- Home
- FF vs ITOS Comparison
FF vs ITOS Comparison
Compare FF & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- ITOS
- Stock Information
- Founded
- FF N/A
- ITOS 2011
- Country
- FF United States
- ITOS United States
- Employees
- FF N/A
- ITOS N/A
- Industry
- FF Major Chemicals
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FF Industrials
- ITOS Health Care
- Exchange
- FF Nasdaq
- ITOS Nasdaq
- Market Cap
- FF N/A
- ITOS 270.7M
- IPO Year
- FF N/A
- ITOS 2020
- Fundamental
- Price
- FF $4.16
- ITOS $6.33
- Analyst Decision
- FF Strong Buy
- ITOS Strong Buy
- Analyst Count
- FF 1
- ITOS 3
- Target Price
- FF $0.80
- ITOS $26.00
- AVG Volume (30 Days)
- FF 316.7K
- ITOS 370.3K
- Earning Date
- FF 03-28-2025
- ITOS 03-05-2025
- Dividend Yield
- FF 5.77%
- ITOS N/A
- EPS Growth
- FF N/A
- ITOS N/A
- EPS
- FF 0.35
- ITOS N/A
- Revenue
- FF $243,339,000.00
- ITOS $35,000,000.00
- Revenue This Year
- FF N/A
- ITOS N/A
- Revenue Next Year
- FF N/A
- ITOS $121.70
- P/E Ratio
- FF $11.89
- ITOS N/A
- Revenue Growth
- FF N/A
- ITOS 177.89
- 52 Week Low
- FF $4.08
- ITOS $6.30
- 52 Week High
- FF $8.36
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- FF 38.44
- ITOS 41.16
- Support Level
- FF $4.08
- ITOS $6.32
- Resistance Level
- FF $4.44
- ITOS $7.05
- Average True Range (ATR)
- FF 0.16
- ITOS 0.32
- MACD
- FF 0.03
- ITOS -0.04
- Stochastic Oscillator
- FF 19.05
- ITOS 28.95
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.